Sarepta Therapeutics Inc (SRPT)
120.40
+1.64
(+1.38%)
USD |
NASDAQ |
Oct 04, 16:00
120.14
-0.26
(-0.21%)
After-Hours: 20:00
Sarepta Therapeutics Shareholders Equity (Annual): 859.34M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 859.34M |
December 31, 2022 | 384.95M |
December 31, 2021 | 928.01M |
December 31, 2020 | 761.76M |
December 31, 2019 | 818.19M |
December 31, 2018 | 1.032B |
December 31, 2017 | 789.22M |
December 31, 2016 | 336.69M |
December 31, 2015 | 190.35M |
December 31, 2014 | 247.65M |
December 31, 2013 | 247.19M |
December 31, 2012 | 123.68M |
December 31, 2011 | 31.02M |
December 31, 2010 | -2.817M |
Date | Value |
---|---|
December 31, 2009 | 23.63M |
December 31, 2008 | 15.73M |
December 31, 2007 | 26.38M |
December 31, 2006 | 37.71M |
December 31, 2005 | 53.66M |
December 31, 2004 | 26.27M |
December 31, 2003 | 43.39M |
December 31, 2002 | 23.48M |
December 31, 2001 | 30.53M |
December 31, 2000 | 33.37M |
December 31, 1999 | 11.90M |
December 31, 1998 | 9.00M |
December 31, 1997 | 18.30M |
December 31, 1996 | 3.90M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
384.95M
Minimum
2022
928.01M
Maximum
2021
750.45M
Average
818.19M
Median
2019
Shareholders Equity (Annual) Benchmarks
Regenxbio Inc | 311.74M |
Catalyst Pharmaceuticals Inc | 387.88M |
Pfizer Inc | 89.01B |
Vertex Pharmaceuticals Inc | 17.58B |
Entrada Therapeutics Inc | 242.36M |